NZ703020A - Method for preparing substituted triazolopyridines - Google Patents
Method for preparing substituted triazolopyridinesInfo
- Publication number
- NZ703020A NZ703020A NZ703020A NZ70302013A NZ703020A NZ 703020 A NZ703020 A NZ 703020A NZ 703020 A NZ703020 A NZ 703020A NZ 70302013 A NZ70302013 A NZ 70302013A NZ 703020 A NZ703020 A NZ 703020A
- Authority
- NZ
- New Zealand
- Prior art keywords
- preparing substituted
- substituted triazolopyridines
- compounds
- triazolopyridines
- preparing
- Prior art date
Links
- 150000008523 triazolopyridines Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12175640 | 2012-07-10 | ||
| EP12185590 | 2012-09-24 | ||
| EP13170585 | 2013-06-05 | ||
| PCT/EP2013/064017 WO2014009219A1 (en) | 2012-07-10 | 2013-07-03 | Method for preparing substituted triazolopyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ703020A true NZ703020A (en) | 2017-08-25 |
Family
ID=48793197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ703020A NZ703020A (en) | 2012-07-10 | 2013-07-03 | Method for preparing substituted triazolopyridines |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9388177B2 (OSRAM) |
| EP (1) | EP2872506A1 (OSRAM) |
| JP (1) | JP6238979B2 (OSRAM) |
| KR (1) | KR20150040845A (OSRAM) |
| CN (1) | CN104603136B (OSRAM) |
| AP (1) | AP3778A (OSRAM) |
| AU (1) | AU2013289381A1 (OSRAM) |
| BR (1) | BR112015000308A2 (OSRAM) |
| CA (1) | CA2878481A1 (OSRAM) |
| CL (1) | CL2015000038A1 (OSRAM) |
| CO (1) | CO7160002A2 (OSRAM) |
| CR (1) | CR20150006A (OSRAM) |
| DO (1) | DOP2015000007A (OSRAM) |
| EA (1) | EA027544B1 (OSRAM) |
| HK (1) | HK1206731A1 (OSRAM) |
| IL (1) | IL236265A (OSRAM) |
| IN (1) | IN2015DN00085A (OSRAM) |
| MX (1) | MX2015000348A (OSRAM) |
| NZ (1) | NZ703020A (OSRAM) |
| PE (1) | PE20150354A1 (OSRAM) |
| PH (1) | PH12015500061A1 (OSRAM) |
| SG (1) | SG11201408419QA (OSRAM) |
| TN (1) | TN2015000008A1 (OSRAM) |
| WO (1) | WO2014009219A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105431435A (zh) * | 2013-06-07 | 2016-03-23 | 拜耳制药股份公司 | 具有作为mps-1抑制剂的活性的取代的三唑并吡啶类 |
| EP3008062B1 (en) * | 2013-06-11 | 2017-04-05 | Bayer Pharma Aktiengesellschaft | Prodrug derivatives of substituted triazolopyridines |
| MX2015017120A (es) | 2013-06-11 | 2016-10-05 | Bayer Pharma AG | Combinaciones para el tratamiento de cancer que comprende un inhibidor de la quinasa mps-1 y un inhibidor de la mitosis. |
| FI3283642T3 (fi) | 2015-04-17 | 2024-01-11 | Crossfire Oncology Holding B V | Prognostisia biomarkkereita ttk-inhibiittorikemoterapiaan |
| TW201800408A (zh) | 2016-06-15 | 2018-01-01 | 拜耳製藥公司 | Mps-1抑制劑 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2003030937A1 (ja) * | 2001-10-05 | 2005-01-20 | 小野薬品工業株式会社 | ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤 |
| WO2005110410A2 (en) * | 2004-05-14 | 2005-11-24 | Abbott Laboratories | Kinase inhibitors as therapeutic agents |
| UA89503C2 (uk) * | 2004-09-13 | 2010-02-10 | Х. Луннбек А/С | Заміщені похідні аніліну |
| JP2008515874A (ja) * | 2004-10-07 | 2008-05-15 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 抗菌薬 |
| US20060194823A1 (en) * | 2004-12-22 | 2006-08-31 | Georg Kettschau | Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof |
| JP2009539840A (ja) * | 2006-06-06 | 2009-11-19 | シェーリング コーポレイション | プロテインキナーゼ阻害剤としてのイミダゾピラジン |
| EP1870416A1 (en) * | 2006-06-21 | 2007-12-26 | Bayer Schering Pharma Aktiengesellschaft | Sulphonamido-macrocycles as tie2 inhibitors |
| JP5336375B2 (ja) | 2006-08-30 | 2013-11-06 | セルゾーム リミテッド | キナーゼ阻害剤としてのトリアゾール誘導体 |
| JO3598B1 (ar) * | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
| AR067562A1 (es) | 2007-07-18 | 2009-10-14 | Novartis Ag | Compuestos heterociclicos inhibidores de kinasa |
| EP2212326A1 (en) | 2007-08-23 | 2010-08-04 | AstraZeneca AB | 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders |
| KR20100075881A (ko) | 2007-08-31 | 2010-07-05 | 메르크 세로노 에스. 에이. | 트리아졸로피리딘 화합물 및 ａｓｋ 저해제로서 이의 용도 |
| GB0719803D0 (en) | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| GB0724342D0 (en) * | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
| WO2009137322A2 (en) * | 2008-05-05 | 2009-11-12 | The Trustees Of The University Of Pennsylvania | Processes for the preparation of biphenyl compounds |
| WO2009155527A2 (en) * | 2008-06-19 | 2009-12-23 | Progenics Pharmaceuticals, Inc. | Phosphatidylinositol 3 kinase inhibitors |
| PE20120110A1 (es) | 2009-02-13 | 2012-02-20 | Fovea Pharmaceuticals | [1,2,4]triazolo[1,5-a]piridinas como inhibidores de cinasa |
| ES2547328T3 (es) | 2009-04-29 | 2015-10-05 | Bayer Intellectual Property Gmbh | Imidazoquinoxalinas sustituidas |
| WO2010141796A2 (en) * | 2009-06-05 | 2010-12-09 | Cephalon, Inc. | PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES |
| WO2010141360A1 (en) * | 2009-06-05 | 2010-12-09 | Merck Sharp & Dohme Corp. | Biaryl benzotriazole derivatives |
| US9340528B2 (en) | 2009-09-04 | 2016-05-17 | Bayer Pharma Aktiengesellschaft | Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| EP2343295A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridine derivates |
| EP2343294A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Substituted triazolopyridines |
| EP2343297A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridines |
| UY33452A (es) * | 2010-06-16 | 2012-01-31 | Bayer Schering Pharma Ag | Triazolopiridinas sustituidas |
| WO2012044567A2 (en) * | 2010-09-30 | 2012-04-05 | Merck Sharp & Dohme Corp. | Imidazole derivatives |
| AP3491A (en) | 2011-04-21 | 2015-12-31 | Bayer Ip Gmbh | Triazolopyridines |
| WO2012160029A1 (en) * | 2011-05-23 | 2012-11-29 | Bayer Intellectual Property Gmbh | Substituted triazolopyridines |
| UA112096C2 (uk) * | 2011-12-12 | 2016-07-25 | Байєр Інтеллектуал Проперті Гмбх | Заміщені триазолопіридини та їх застосування як інгібіторів ttk |
-
2013
- 2013-07-03 MX MX2015000348A patent/MX2015000348A/es unknown
- 2013-07-03 JP JP2015520907A patent/JP6238979B2/ja not_active Expired - Fee Related
- 2013-07-03 IN IN85DEN2015 patent/IN2015DN00085A/en unknown
- 2013-07-03 US US14/414,164 patent/US9388177B2/en not_active Expired - Fee Related
- 2013-07-03 AP AP2014008177A patent/AP3778A/en active
- 2013-07-03 SG SG11201408419QA patent/SG11201408419QA/en unknown
- 2013-07-03 AU AU2013289381A patent/AU2013289381A1/en not_active Abandoned
- 2013-07-03 CN CN201380045913.9A patent/CN104603136B/zh not_active Expired - Fee Related
- 2013-07-03 CA CA2878481A patent/CA2878481A1/en not_active Abandoned
- 2013-07-03 NZ NZ703020A patent/NZ703020A/en not_active IP Right Cessation
- 2013-07-03 HK HK15107242.4A patent/HK1206731A1/xx unknown
- 2013-07-03 EP EP13737181.1A patent/EP2872506A1/en not_active Withdrawn
- 2013-07-03 WO PCT/EP2013/064017 patent/WO2014009219A1/en not_active Ceased
- 2013-07-03 BR BR112015000308A patent/BR112015000308A2/pt not_active IP Right Cessation
- 2013-07-03 EA EA201590116A patent/EA027544B1/ru not_active IP Right Cessation
- 2013-07-03 PE PE2015000017A patent/PE20150354A1/es not_active Application Discontinuation
- 2013-07-03 KR KR20157000338A patent/KR20150040845A/ko not_active Withdrawn
-
2014
- 2014-12-15 IL IL236265A patent/IL236265A/en not_active IP Right Cessation
-
2015
- 2015-01-07 TN TNP2015000008A patent/TN2015000008A1/fr unknown
- 2015-01-08 CL CL2015000038A patent/CL2015000038A1/es unknown
- 2015-01-09 CR CR20150006A patent/CR20150006A/es unknown
- 2015-01-09 PH PH12015500061A patent/PH12015500061A1/en unknown
- 2015-01-09 CO CO15004251A patent/CO7160002A2/es unknown
- 2015-01-09 DO DO2015000007A patent/DOP2015000007A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013289381A1 (en) | 2015-01-22 |
| HK1206731A1 (en) | 2016-01-15 |
| MX2015000348A (es) | 2015-04-14 |
| CN104603136A (zh) | 2015-05-06 |
| EA201590116A1 (ru) | 2015-07-30 |
| BR112015000308A2 (pt) | 2017-06-27 |
| EP2872506A1 (en) | 2015-05-20 |
| PE20150354A1 (es) | 2015-03-21 |
| CL2015000038A1 (es) | 2015-03-13 |
| JP6238979B2 (ja) | 2017-11-29 |
| IN2015DN00085A (OSRAM) | 2015-05-29 |
| AP3778A (en) | 2016-08-31 |
| DOP2015000007A (es) | 2015-02-15 |
| PH12015500061A1 (en) | 2015-03-02 |
| JP2015523372A (ja) | 2015-08-13 |
| EA027544B1 (ru) | 2017-08-31 |
| WO2014009219A1 (en) | 2014-01-16 |
| CO7160002A2 (es) | 2015-01-15 |
| CA2878481A1 (en) | 2014-01-16 |
| US20150148542A1 (en) | 2015-05-28 |
| CR20150006A (es) | 2015-02-16 |
| IL236265A (en) | 2017-07-31 |
| IL236265A0 (en) | 2015-02-26 |
| AP2014008177A0 (en) | 2014-12-31 |
| TN2015000008A1 (en) | 2016-06-29 |
| KR20150040845A (ko) | 2015-04-15 |
| US9388177B2 (en) | 2016-07-12 |
| SG11201408419QA (en) | 2015-01-29 |
| CN104603136B (zh) | 2017-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2012213775A8 (en) | 7-azaindole derivatives | |
| MD20150091A2 (ro) | Compuşi antivirali | |
| UA111186C2 (uk) | Способи та композиції для одержання норибогаїну з воакангіну | |
| MY167697A (en) | Method for producing 4,4-difluoro-3,4- dihydroisoquinoline derivatives | |
| MX2015005944A (es) | Cepas microbianas, composiciones y metodos para incrementar el fosfato disponible para las plantas. | |
| EA201491195A1 (ru) | Способ получения композиции, содержащей галактоолигосахариды | |
| PH12014501258A1 (en) | Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof | |
| EA201590887A1 (ru) | Композиция | |
| PH12013502169A1 (en) | Triazolopyridines | |
| IN2015KN00323A (OSRAM) | ||
| GEP201706690B (en) | Novel process for making compounds for use in treatment of cancer | |
| MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
| GEP201706626B (en) | Synthesis of (s)-nifuratel | |
| PH12015500061A1 (en) | Method for preparing substituted triazolopyridines | |
| GB201107985D0 (en) | Process | |
| IN2014DN09451A (OSRAM) | ||
| AU2012248013B2 (en) | Intermediate for synthesizing caspofungin and preparation method therefor | |
| MX367773B (es) | Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos. | |
| WO2013072938A3 (en) | Process for the preparation of roflumilast | |
| TN2015000095A1 (en) | Macrolide derivatives, preparation thereof and therapeutic use thereof | |
| IN2014DN10135A (OSRAM) | ||
| IN2014DN07407A (OSRAM) | ||
| IN2015DN02513A (OSRAM) | ||
| PH12015502703A1 (en) | Pharmaceutical compositions | |
| IN2013MU01219A (OSRAM) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| LAPS | Patent lapsed |